Press Releases At Pulmatrix, we are committed to communicating clear and consistent information. Here we feature current and historic content concerning our science, our pipeline, and our corporate initiatives and achievements. Please check in often for the most recent press releases and information. Investor Alerts Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 Keywords Go Advanced Search NOV 10, 2021 Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update Pulmazole contract dispute with Cipla resolved, expect to initiate Ph2b study in Q1 2023 for treatment of Allergic Bronchopulmonary Aspergillosis (ABPA) Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented... NOV 9, 2021 Pulmatrix Announces Resolution of Contract Dispute with Cipla Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented... AUG 10, 2021 Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business Update PUR1800 Phase 1b study is fully enrolled with data anticipated in Q1 2022 Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented... JUL 27, 2021 Pulmatrix appoints Director Anand Varadan Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented... MAY 11, 2021 Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business Update PUR1800 Phase 1b data anticipated in Q4 2021 Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented... Show 5 per page «123456789…29» 2021 PULMATRiX, Inc. Produced in the USA. Terms of UsePrivacy StatementContact Us

In The News Year All Years 2021 2020 2019 2018 2017 2016 Keywords Go Advanced Search JUN 26, 2017 Pediatrics of Stanford University – June 26, 2017 MAY 22, 2017 NewsUSA – May 22, 2017 MAY 17, 2017 Stock Sector – May 17, 2017 FEB 8, 2017 CEOCFO Magazine – February 8, 2017 DEC 20, 2016 CEOCFO Magazine – December 20, 2016 SEP 28, 2016 CEOCFO Magazine – September 28, 2016 AUG 23, 2016 CEOCFO Magazine – August 23, 2016 JUL 19, 2016 Boston Business Journal – July 19, 2016 JUN 2, 2016 Stock Sector – June 2, 2016 MAY 23, 2016 CEOCFO Magazine – May 23, 2016 APR 19, 2016 ONdrugDelivery Magazine – April 19, 2016 APR 18, 2016 CEOLIVE.TV – April 18, 2016 MAR 23, 2016 TheStockRadio.com – March 23, 2016 MAR 15, 2016 GEN Exclusives – March 15, 2016 MAR 6, 2016 PharmaExec.com – March 6, 2016 FEB 1, 2016 PharmaVOICE – February 2016 FEB 1, 2016 healtheo360.com – February 2016 2021 PULMATRiX, Inc. Produced in the USA. Terms of UsePrivacy StatementContact Us